Manila Gaddh
Academic Appointment
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MBBS from Lady Hardinge Medical College
Research
Focus
- My research focus is on thrombosis in cancer patients and bone marrow failure syndromes. I am currently involved in developing an evidence-based algorithmic approach to evaluation of thrombotic disorders, and am working towards exploring the feasibility of novel therapies, including combined thrombectomy and low dose anticoagulation, for treatment of thrombosis in cancer patients.
Publications
-
Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study.
Res Pract Thromb Haemost Volume: 9 Page(s): 102856
05/01/2025 Authors: Elsebaie MAT; Wickham Z; DeBragga S; Fedewa S; Amgad M; Park JJ; Li A; Eshaghpour A; Li J; Crowther M -
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
Chest Volume: 165 Page(s): 785 - 799
04/01/2024 Authors: Greenstein YY; Hubel K; Froess J; Wisniewski SR; Venugopal V; Lai Y-H; Berger JS; Chang SY; Colovos C; Shah F -
Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen.
Blood Volume: 140 Page(s): 1983 - 1992
11/03/2022 Authors: Simon B; Cegldi A; Dolgos J; Farkas P; Gaddh M; Hank L; Horvth R; Kaposi A; Magyar L; Masszi T -
Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study.
EJHaem Volume: 3 Page(s): 457 - 462
05/01/2022 Authors: Scott LC; Li J; Cafuir LA; Gaddh M; Kempton CL -
Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment.
Res Pract Thromb Haemost Volume: 6 Page(s): e12740
05/01/2022 Authors: Groat D; Martin KA; Rosovsky RP; Sanfilippo KM; Gaddh M; Kreuziger LB; Eyster ME; Woller SC; Venous thromboEmbolism Network US (VENUS) VTE Treatment, Anticoagulation Management Group -
Preliminary Analysis of the Association Between Therapeutic-Dose Anticoagulation and Long Term Outcomes from the ACTIV-4a and ATTACC Multiplatform Adaptive Trial of Hospitalized Patients with COVID-19
Volume: 205
05/01/2022 Authors: Greenstein YY; Hubel K; Venugopal V; Lai Y; Berger JS; Chang SY; Colovos C; Shah FA; Islam M; Ceja JJ -
Preliminary Analysis of the Symptoms and Quality of Life After Discharge in Noncritically Ill Patients with COVID-19: The ACTIV-4a and ATTACC Randomized Controlled Trial
Volume: 205
05/01/2022 Authors: Hubel KA; Greenstein YY; Venugopal V; Lai Y; Berger JS; Chang SY; Colovos C; Shah F; Islam M; Jimenez J -
Clinical Outcomes of Critically III Patients with COVID-19 by Race.
J Racial Ethn Health Disparities Volume: 9 Page(s): 385 - 389
04/01/2022 Authors: Marmarchi F; Liu M; Rangaraju S; Auld SC; Creel-Bulos MC; Kempton CL; Sharifpour M; Gaddh M; Sniecinski R; Maier CL -
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.
Blood Adv Volume: 5 Page(s): 5546 - 5553
12/28/2021 Authors: Carney BJ; Wang T-F; Ren S; George G; Al Homssi A; Gaddh M; Connolly GC; Shah VI; Bogue T; Bartosic A -
County-Level Social Vulnerability Is Associated with Increased Risk for Venous Thromboembolism in COVID-19
Volume: 233 Page(s): S319 - S319
11/01/2021 Authors: Meena RA; Di M; Wiley Z; Gaddh M; Patzer RE; Alabi O